Transvetzuren ontstaan bij hydrogenering
van plantaardige vloeibare olie (zonnebloemolie, sojaolie etc) naar vaste vetten, deze
vetten blijven langer houdbaar en worden oa gebruikt voor het bakken van fastfood, chips,
bakkerijprodukten, patat etc. Terwijl men in Nederland bang is gemaakt voor verzadigde
dierlijke vetten vergeet men de echte gevaarlijke vetten in de industriefood en fastfood
produkten.
Op de labels van produkten staan echter
alleen de waardes van verzadigd vet maar niet de waardes van de veel gevaarlijker
transvetzuren die volop aanwezig zijn in de fastfood/industrie voeding.
In Amerika is dit sinds 2005 echter wel
verplicht maar Europa maakt zich liever drukker om andere zaken. Deze ambtenarij zorgt
iedere dag weer voor dodelijke slachtoffers zonder dat de media zich er echt druk om
maken. Omdat de kranten weer eens zwijgen een kleine opsomming van de risico's mbt
transvetzuren. Het ontstaan van deze vetzuren vindt u op deze pagina:
De Deense overheid heeft al in 2003
drastisch stappen genomen om haar bevolking te beschermen tegen deze gevaarlijke vetzuren.
Het is te hopen dat in 2006 ook het muntje valt bij de heren in Den Haag.....
De risico's van transvetzuren:
Verhoogde kans op aderverkalking
Negatieve effecten op groei van de foetus
Verhoogde kans op diabetes
Tien keer grotere kans op hart en
vaatziektes !!!
Verhoogde kans op allergie bij kinderen
Het Deense onderzoek noemt ook de
verschillen qua risico op hart- en vaatziektes bij verzadigd vet en transvetzuren:
Dagelijkse inname van 5 gram verzadigd
vet > 2% extra risico
Dagelijkse inname van 5 gram transvetzuren > 25% extra risico
De Amerikaanse FDA noemt 2 gram per dag als
redelijk veilig.
Een klein zakje franse frietjes bevat al 3.5 gram, een zakje magnetron popcorn maar liefst
10 gram.....
In 1996 stond Nederland samen met Ijsland
bovenaan de Europese lijst qua inname per persoon van transvetzuren (4.3 gram per dag).
Laagste land was Griekenland met gemiddeld 1.4 gram per persoon per dag.
In Engeland komt er ook steeds meer verzet
tegen produkten met transvetzuren. Men wil dat Europa Denenmarken gaat volgen en het
publiek informeert over de hoeveelheden transvetzuren in produkten zodat de consument weet
wat hij koopt. Een mogelijk alternatief voor harde plantaardige vetten zou
palmvet/kokosvet kunnen zijn. Een speler uit Nederland op dit gebied is Loders Croklaan.
Amerikaanse onderzoekers noemen ook een
verhoogde kans op galstenen bij mensen die een hogere inname van transvetzuren hebben.
Ron
Meer doden door transvetten dan in het
verkeer !
En wat doet de overheid? Helemaal niets, in
dit geval wordt de vervuiler beloond en kijkt de overheid toe. Dit noemen ze in Den Haag
preventie.
Video - De Gevaren van Transvet,
(gedeeltelijk) gehard vet, geharde olie
Transvetten (transvetzuren) zijn kunstmatig
gefabriceerde vetten die zeer slecht zijn voor uw gezondheid. De gezondheids risico's van
transvetten: obesitas, kanker, dichtslibben van de aderen, geboorte afwijkingen, diabetes,
hoge cholesterol, hart en vaatziektes, allergie bij kinderen, etc.
Voedingsproducten bevatten transvet als er
één van de volgende ingredienten bevat: (gedeeltelijk) gehard vet, (gedeeltelijk)
geharde olie, gehydrogeneerde vet/olie.
Doe uw gezondheid een plezier en verwijder
deze chemische substantie uit uw voeding!
"Mijn volk gaat te gronde door het
gebrek aan kennis." Hosea 4:6 (NBG51)
"Wijsheid verwerven, inzicht
verkrijgen, dat moet je boven alles gaan." Spreuken 4:7 (GNB96)
Opnieuw een hoofdrol voor transvetzuren, de
zogenaamde geharde plantaardige vetten, die met name voorkomen in industrievoeding,
fabrieksbrood (supermarkten zoals Aldi, Plus etc etc ) en het beruchte koffiemelkpoeder
(1/3 gehard vet!!) dat sommige mensen iedere dag in hun koffie doen (met name
koffiemachines op het werk). Ditmaal een relatie tussen inname van transvetzuren door
zwangere moeders en het effect op het vet van de baby. Bij ratten zorgde dit voor 40%
vettoename en verhoogde insuline produktie (dus meer kans op diabetes 2).
Vermijdt dus alles dat geharde plantaardige
vetten bevat, de supermarkten liggen er vol mee, fabrikanten blijven deze ziekmakers dag
in dag uit gebruiker omdat ze goedkoop zijn, ten kosten van uw gezondheid !
Ron
Pregnant mothers' diet linked to baby's
obesity
Pregnant and lactating rats fed on a diet of hydrogenated fat during pregnancy and
lactation had babies who were fatter than rats fed a normal diet, according to research
published in Lipids in Health and Disease. The unhealthy diet has deleterious consequences
even after the fats were removed from the diet and has links to insulin production.
We know that foetal growth is
influenced by the mothers nutritional status, explained Brazilian nutritionist
Luciana Pisani. The nutritional conditions during pregnancy has a major role in the
metabolic and hormonal interactions between the mothers body, placenta and foetus.
To date only a few studies have looked at the effects on trans fatty acids during
pregnancy and lactation on the metabolism of offspring in adulthood. We found that the
fatty content of the babies bodies increased when the mothers were fed the
hydrogenated fat rich diet and this could be traced to the gene expression of
adipokines.
In an investigation to examine whether
feeding pregnant and lactating rats hydrogenised fats rich in trans fatty acids, increased
the fat content in carcass, the researchers found that their metabolic rate dropped
dramatically. Interestingly young rats that were fed a normal diet after they were born
ate less and weighed less even though their mothers had been eating the trans fatty acids
while pregnant. The gene expression of adipokines was also examined in relation to insulin
production.
The offspring were weighed weekly and
exposure to the trans-fatty acid enriched diet after weaning led to a 40% increase in body
fat content for the young rats. Rats whose mothers were fed the trans fatty acids and
continued to eat the fats into adulthood had the highest metabolic efficiency. The same
rats increased their insulin production.
Pisani continued, Fats play a
fundamental role in foetal development and changes in dietary fatty acids has important
implications for foetal and postnatal development. Heavy ingestion of very hydrogenated
fats rich in trans fatty acids increases risk of cardiovascular diseases and reduces
insulin sensitivity and so leads to type 2 diabetes. We need to investigate this further
as this has important implications for peoples own diets, especially pregnant
women.
Natuurlijke transvetzuren in zuivel
en vleesprodukten geen probleem
Natural trans fats have health benefits,
University of Alberta study shows
Contrary to popular opinion, not all trans fats are bad for you.
University of Alberta researcher Flora Wang
found that a diet with enriched levels of trans vaccenic acid (VA) a natural animal
fat found in dairy and beef products can reduce risk factors associated with heart
disease, diabetes and obesity Results indicated this benefit was due in part to the
ability of VA to reduce the production of chylomicrons particles of fat and
cholesterol that form in the small intestine following a meal and are rapidly processed
throughout the body. The role of chylomicrons is increasingly viewed as a critical missing
link in the understanding of conditions arising from metabolic disorders. Our
results provide further evidence of the important role of chylomicrons in contributing to
risk factors associated with metabolic disorders, said Wang, a PhD candidate in the
University of Alberta Faculty of Agricultural, Life and Environmental Sciences. They
also indicate a strong opportunity for using diets with enhanced VA to help reduce these
risk factors. The research involved two VA feeding trials one short-term
(three weeks) and one long-term (16 weeks) using model rat species for obesity and
the metabolic syndrome. The results, presented recently at the International Symposium on
Chylomicrons in Disease, included novel findings that VA may have direct effects on the
intestine. In addition, they showed key metabolic risk factors were reduced. For example,
in the long-term trial, total cholesterol was lowered by approximately 30 per cent, LDL
cholesterol was lowered by 25 per cent and triglyceride levels were lowered by more than
50 per cent. Because VA is the major natural trans fat in dairy and beef products,
comprising more than 70 per cent of the proportion of natural trans fat content in those
products, the findings support a growing body of evidence that indicates natural
animal-based trans fat is different than harmful hydrogenated trans fat created through
industrial processing, Wang noted. As the VA results illustrate, some natural trans
fats are not harmful and may in fact be very good for you, she said.
Transvetzuren (gehard plantaardig
vet) slecht voor neurologische
ontwikkeling kinderen
Recentelijk is er onderzoek gedaan naar de
relatie tussen de neonatale transvetzuur status en de neurologische ontwikkeling van
gezonde op tijd geboren kinderen. Er kwam uit naar voren dat hoe meer transvetzuren er in
de navelstreng van het kind zaten des te slechter de neurologische conditie van het kind
op 18 maanden. Dit is de eerste keer dat de relatie tussen transvetzuren en neurologische
ontwikkeling in een grote groep bekeken is.
Referentie: Bouwstra H, Dijck-Brouwer J,
Decsi T, Boehm G, Boersma ER, Muskiet FA, Hadders-Algra M. Neurologic condition of healthy
term infants at 18 months: positive association with venous umbilical DHA
status and negative association with umbilical trans-fatty acids. Pediatr Res.
2006;60:334-9.
Foute transvetzuren zorgen voor
extra gewichtstoename
Uit de bekende Nurses Health Study blijkt
dat vrouwen die regelmatig transvetzuren eten zwaarder zijn geworden dan vrouwen die
andere vetten eten. Voor elke procent (van de calorien) meer die uit transvet komt is een
toename van 1 kilo in 8 jaar. Komt dus 6% van je caloriën uit transvetten dan kom je in
bijvoorbeeld 16 jaar 12 extra kilo's aan. Transvetten zitten oa in geharde plantaardige
vetten, patat van een ongezond bakkende cafetaria (60% vd cafetaria's in Nederland) ,
muffins, cake, koekjes, melkpoeder. In de jaren 80 was met name frituurvet en margarine de
boosdoener met percentages transvet tussen de 24 en 65% terwijl de Deense norm nu 0.5%
is.......
Op dit moment liggen de transvetzuren onder
vuur. Amerika en Canada hebben labelverplichting, Denmark zeer strenge regels voor
produkten die in het land geconsumeerd worden maar alleen Europa pakt op zijn dooie gemak
de transvetzuren aan. De industrie kan in alle rust de produkten aanpassen en ook
cafetaria's die niet gezond willen bakken worden niet genoemd op de site gezond frituren.
De Europese consument mag nog steeds niet weten wat we kopen dus je kunt alleen afgaan op
labels waarop staat (gedeeltelijke) gehard plantvaardige vet. Met name gebak, croissants,
broodjes, koekjes, chips waar goedkope vetten zijn gebruikt bevatten deze zeer gevaarlijke
vetten.
Bij het maken van croissants wordt soms
slechte, ongezonde margarine gebruikt. De afbakcroissants van de merken Schoof,
Croissants en Euro-bread (te koop bij Jumbo, Super de Boer, Plus en Hoogvliet) bevatten
daardoor onnodig veel van het schadelijke transvet. Dat blijkt uit onderzoek van de
Consumentenbond. In goede margarine is het gehalte transvet praktisch nul. Daarom is het
vreemd dat juist de margarine-afbakcroissants van Schoof, Croissants en Euro-bread
het meeste transvet bevatten, méér dan de roomboter-croissants. Dat duidt op het gebruik
van ouderwetse en goedkope margarine.
A debate on the phasing-out of industrially
produced trans fatty acids in food products has been initiated over the last few years in
the EU, and particularly in the USA. In Denmark, this debate started in 1994 following the
publication of the Danish Nutrition Councils first report, which actually dealt with
trans fatty acids and contributed to a significant fall in the consumption of these fatty
acids by Danes.
On March 11, 2003 the Danish government
decided to phase out the use of industrially produced trans fatty acids in food before the
end of 2003. We hope that this report can provide a useful tool in work on eliminating
these fatty acids, which are harmful to health, from food products, also in countries
outside Denmark.
The report The influence of trans
fatty acids on health published
in 1994 by the Danish Nutrition Council concluded that trans
fatty acids in the diet promote arteriosclerosis at least as much as
equivalent amounts of saturated fats and probably more, and that
there are justified suspicions that a high trans fatty acid intake may
have adverse effects on foetal growth. It was therefore recommended
that a declaration of trans fatty acid levels in foodstuffs be dealt
with by the EU. An agreement was also concluded with the Danish
margarine industry to reduce the trans fatty acid content of margarines
produced in Denmark.
Since 1994, the influence of a high intake
of industrially produced
trans fatty acids in promoting the development of heart disease has
been further documented by, among other things, the presentation of
four major prospective population studies. The studies indicate that,
gram for gram, the intake of trans fatty acids as compared with saturated
fatty acids is associated with an approximately 10-fold higher risk
increment for the development of heart disease. The suspicion of an
adverse effect of trans fatty acids early in life has been further confirmed.
The possible effect of trans fatty acids on the development of cancer is
still unclarified. Data from both epidemiological and mechanism
studies gives rise to the justified suspicion that trans fatty acids increase
the risk of type 2 diabetes. Studies have also been presented justifying
further studies concerning the possible effect of trans fatty acids in
promoting allergic diseases in children and concerning the possible
influence of trans fatty acids on body fat distribution and insulin
sensitivity.
Monkeys fed a diet rich in trans-fats
commonly found in fast foods grew bigger bellies than those fed a diet rich
in unsaturated fats, but containing the same overall number of calories. They also
developed signs of insulin resistance, which is an early indicator of diabetes.
Food Industry Mulls Dropping
Obesity-Linked Trans Fats
Trans fats have been fingered as a major
culprit in America's bourgeoning obesity problem, in increasing the risk of heart disease
- and they are possibly also a factor behind childhood allergies, asthma, and other
conditions.
The Danger of Hydrogenated or
Partially Hydrogenated Fats
Increases blood insulin levels in humans in
response to glucose load, increasing risk for diabetes;
Raises the LDL cholesterol in a dose response manner;
Lowers the "good" HDL cholesterol in a dose response manner (the higher the
trans level in the diet, the lower the HDL cholesterol in the serum);
The fast food chain KFC is being sued for the fat content in its fried chicken, which
Center for Science in the Public Interest says contains "staggering amounts" of
trans fat.
One three-piece Extra Crispy combo meal has 15 grams of trans fat, which is more trans fat
than a person should have in one week, says the CSPI.
A gram of trans fat is four- to ten times
more dangerous to heart health than a gram of saturated fat, and the World Health
Organization has recommended countries move as Denmark did last year to
eliminate transfats. At about 10 grams a day, Canada has one of the worlds highest
consumption rates of transfats. The New England Journal of Medicine says consuming one
gram a day increases the risk of heart disease by 20 per cent.
"Families want protection from
dangerous trans fats and the NDPs calling on all parties to provide it," said
Layton. "Canada should move as quickly as we can to get dangerous transfats out of
the food our families eat. Lets show Ottawa can listen to people and respond to
their concerns and improve public health in the process.
"Transfats are found everywhere and
are a clear danger to Canadians hearts," said Layton. "And with transfats
being most prevalent in highly processed foods, low-income and older Canadians are
particularly at risk. Its time to act against transfats, and pass sensible
legislation that requires the food industry to get it out of families food
faster."
The Food and Drug Administration (FDA) now
requires food manufacturers to list trans fat (i.e., trans fatty acids) on Nutrition Facts
and some Supplement Facts panels. Scientific evidence shows that consumption of saturated
fat, trans fat, and dietary cholesterol raises low-density lipoprotein (LDL or
"bad") cholesterol levels that increase the risk of coronary heart disease
(CHD). According to the National Heart, Lung, and Blood Institute of the National
Institutes of Health, over 12.5 million Americans suffer from CHD, and more than 500,000
die each year. This makes CHD one of the leading causes of death in the United States
today.
FDA has required that saturated fat and
dietary cholesterol be listed on the food label since 1993. By adding trans fat on the
Nutrition Facts panel (required by January 1, 2006), consumers now know for the first time
how much of all three -- saturated fat, trans fat, and cholesterol -- are in the foods
they choose. Identifying saturated fat, trans fat, and cholesterol on the food label gives
consumers information to make heart-healthy food choices that help them reduce their risk
of CHD.
This revised label, which includes
information on trans fat as well as saturated fat and cholesterol, will be of particular
interest to people concerned about high blood cholesterol and heart disease. However, all
Americans should be aware of the risk posed by consuming too much saturated fat, trans
fat, and cholesterol. But what is trans fat, and how can you limit the amount of this fat
in your diet?
Trans fat information is coming to
a food label near you!
This really is big news. For years you've
probably been avoiding saturated fats in foods while trans fats have escaped unnoticed.
These "stealth fats" will no longer be able to hide in food and do their damage
to your health without your knowledge. The Food and Drug Administration established a rule
in 2003 requiring food manufacturers and makers of some dietary supplements to include
trans fat information on the nutrition label of their products. All food labels must
include this information by 2006, although some manufacturers are beginning to make the
change already.
While reviewing guidelines on daily
requirements for protein, fat, and carbohydrates, the Institute of Medicine drafted a
letter to the Food and Drug Administration on trans fats. Here's the institute's bottom
line: There's no safe daily level for trans fat intake, and we should eat as little of
them as possible.
That might be easier to do if you could
tell if trans fats are in a food and, if they are, how much it contains. Take one of
Entenmann's Rich Frosted Donuts. According to the Center for Science in the Public
Interest, the five grams of saturated fat listed on its label are bad enough. But when you
add in the unlisted five grams of trans fat, the total is half a day's allotment of
unhealthy fat.
New tests find that McDonald's French fries contain higher levels of trans fats than
previously disclosed. The new tests found 8 grams of trans fats in a large servinig of
fries -- one-third more than McDonald's claimed. Trans fats contribute to harmful
cholesterol buildup and heart disease. Official U.S. government dietary guidelines
recommend next to zero consumption of trans fats.
Our results suggest that a higher intake of
trans-fatty acids modestly increases risk of gallstone disease. This adds to the concern
that partial hydrogenation of vegetable oils to form shortening and margarine can lead to
adverse health effects, conclude the researchers in the May 9 issue of the Archives
of Internal Medicine.
The European Food Safety Authority has said
that they may cause more damage than saturated fats. Some think that as little as 1g a day
will significantly increase your risk of heart disease." Trans fats raise the levels
of "bad" (LDL) cholesterol in the blood, and lower the levels of
"good" (HDL) cholesterol, so increasing your risk of coronary heart disease.
They have also been linked to type-2 diabetes.
Marks & Spencers commitment to
remove all hydrogenated fats from its entire food range by mid 2006 suggests that
awareness of trans fats has now fully hit Europe.
The firm is the first major retailer in the
UK to place a blanket ban on hydrogenated fats, and could set in place a trend that
snowballs, with consumer choice increasingly informed by health and nutritional knowledge.
Salmerón J, Dr., Unidad de Investigación
Epidemiológica y en Servicios de Salud,Instituto Mexicano del Seguro Social, Cuernavaca
Morelos, México.
Conclusions: These data suggest that total fat and saturated and monounsatu-rated fatty
acid intakes are not associated with risk of type 2 diabetes in women,but that trans
fatty acids increase and polyunsaturated fatty acids reduce risk.
Substituting nonhydrogenated polyunsaturated fatty acids for trans fatty acids would
likely reduce the risk of type 2 diabetes substantially. Based on the previously reported
data: Dietary fat intake and risk of type 2 diabetes in women Salmerón J, Hu FB, Manson
JA, Stampfer MJ, Colditz GA, Rimm EB, Willett WC. Am J Clin Nutr 2001;73:1019-26.
Sampugna J et al. Rapid analysis of trans
fatty acids on SP-2340 glass
capillary columns. J Chromastogr 1982; 249: 245-55.
Wahle KWJ, James WPT. Isomeric fatty acids
and human health.
Eur J Clin Nutr 1993; 47: 828-39.
Stender S, Dyerberg J, Hřlmer G, Ovesen L,
Sandström B.
The influence of Trans Fatty Acids on Health: a report from the
Danish Nutrition Council. Clin Sci 1995;88:375-92.
Willett WC, Stampfer MJ, Manson JE, Colditz
GA, Speizer FE,
Rosner BA et al. Intake of trans fatty acids and risk of coronary heart
diseases among women. Lancet 1993; 341: 581-5.
Aro A, Kardinaal AF, Salminen I et al.
Adipose tissue isomeric
trans fatty acids and risk of myocardial infarction in nine countries:
the EURAMIC study. Lancet 1995; 345: 273-8.
Aro A. Epidemiology of trans fatty acids
and coronary heart disease in
Europe. Nutr Metab Cardiovasc Dis 1998; 8: 402-7.
Roberts TL, Wood DA, Riemersma RA,
Gallagher PJ, Lampe FC.
Trans isomers of oleic and linoleic acids in adipose tissue and sudden
cardiac death. Lancet 1995; 345: 278-82.
Pedersen JI, Ringstad J, Almendingen K,
Haugen TS, Stensvold I,
and Thelle DS. Adipose tissue fatty acids and risk of myocardial
infarction a case-control study. Eur J Clin Nutr 2000; 54: 618-25.
Ascherio A, Rimm EB, Giovannucci EL,
Spiegelman D, Stampfer M,
Willett WC. Dietary fat and risk of coronary heart disease in men:
cohort follow up study in the United States. BMJ 1996; 313: 84-90.
Pietinen P, Ascherio A, Korhonen P, Hartman
AM, Willett WC,
Albanes D, Virtamo J. Intake of fatty acids and risk of coronary
heart disease in a cohort of Finnish men. The Alpha-Tocopherol,
Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997 15;
145(10): 876-87.
Hu FB, Stampfer MJ, Manson JE, et al.
Dietary fat intake and the
risk of coronary heart disease in women. N Engl J Med 1997; 337:
1491-9.
Oomen CM, Ocké MC, Feskens EJM, van
Erp-Baart MJ, Kok FJ,
Kromhout D. Association between trans fatty acid intake and 10-year
risk of coronary heart disease in the Zutphen Elderly Study: a
prospective population-based study. Lancet 2001; 357: 746-51.
Thom TJ, Epstein FH. Heart disease, cancer,
and stroke mortality.
Trends and their interrelations. An international perspective.
Circulation 1994; 90: 574-82.
Zegarska Z, Borejszo Z. Trans fatty acid
content of some food
products in Poland. J Food Lipids 2001; 8: 271-9.
Ascherio A, Katan MB, Stampfer MJ, Willett
WC. Trans Fatty Acids
and Coronary Heart Disease. Sounding Board. N Engl J Med 1999;
340(25): 1994-7.
Lichtenstein AH, Ausman LM, Jalbert SM,
Schaefer EJ. Effects of
different forms of dietary hydrogenated fats on serum lipoprotein
cholesterol levels. N Engl J Med 1999; 340(25): 1933.
Katan MB, Zock PL, Mensink RP. Trans fatty
acids and their effects
on lipoproteins in humans. Annu Rev Nutr 1995; 15: 473-93.
Dashti N, Feng Q, Freeman MR, Gandhi M,
Franklin FA.
Trans Polyunsaturated Fatty Acids Have More Adverse Effects than
Saturated Fatty Acids on the Concentration and Composition of
Lipoproteins Secreted by Human Hepatoma HepG2 Cells.
J Nutr. 2002:132;2651-9.
Clevidence BA, Judd JT, Schaefer EJ, Jenner
JL, Lichtenstein AH,
Muesing RA, Wittes J, Sunkin ME. Plasma Lipoprotein (a) Levels in
Men and Women Consuming Diets Enriched in Saturated, Cis-, or
Trans-Monounsaturated Fatty Acids. Arterioscler Thromb Vasc Biol
1997; 17: 1657-61.
Mauger J-F, Lichtenstein AH, Ausman LM,
Jalbert SM, Jauhiainen
M, Ehnholm C, Lamarche B. Effect of different forms of dietary
hydrogenated fats on LDL particle size 1-3. Am J Clin Nutr 2003;
78: 370-5.
Stensvold I, Tverdal A, Urdal P,
Graff-Iversen S. Non-fasting serum
triglyceride concentration and mortality from coronary heart disease
and any cause in middle aged Norwegian women. BMJ 1993; 307:
1318.
Jeppesen J, Hein HO, Suadicani P,
Gyntelberg F. Low Triglycerides-
High High-Density Lipoprotein Cholesterol and Risk of Ischemic
Heart Disease. Arch Intern Med 2001; 161: 361-6.
Stampfer MJ, Sacks FM, Salvini S, Willett
WC, Hennekens CH.
A prospective study of cholesterol, apolipoproteins, and the risk of
myocardial infarction NEJM 1991; 325: 373-81.
McLennan OL. Relative effects of dietary
saturated,
monounsaturated, and polyunsaturated fatty acids on cardiac
arrhythmias in rats. Am J Clin Nutr 1993; 57: 207-12.
Christensen JH, Skou HA, Fog L, Hansen VE,
Vesterlund T,
Dyerberg J, Toft E, Schmidt EB. Marine n-3 Fatty Acids, Wine
Intake, and Heart Rate Variability in Patients Referred for Coronary
Angiography. Circulation 2001; 103: 651-7.
Schmidt EB, Skou HA, Christensen JH, and
Dyerberg J. n-3 fatty
acids from fish and coronary artery disease: implications for public
health. Public Health Nutrition, 1999; 3(1): 91-8.
Burr ML, Fehily AM, Gilbert JF, et al.
Effects of changes in fat, fish,
and fibre intakes on death and myocardial infarction: Diet And
Reinfarction Trial (DART). Lancet 1989; 2: 757-61.
GISSI-Prevenzione Investigators. Dietary
supplementation with
n-3 poly-unsaturated fatty acids and vitamin E after myocardial
infarction: results of the GISSI-Prevenzione trial: Gruppo Italiano
per lo Studio della Sopravvivenza nellInfarto miocardico. Lancet
1999; 354: 447-55.
Lemaitre RN, King IB, Raghunathan TE,
Pearce RM, Weinmann S,
Knopp RH. Cell membrane Trans-Fatty Acids and the Risk of
Primary Cardiac Arrest. Circulation. 2002; 105: 697-701.
de Ross NM, Bots ML, Katan MB. Replacement
of dietary saturated
fatty acids by trans fatty acids lowers serum HDL cholesterol and
impairs endothelial function in healthy men and women. Arterioscler
Thromb Vasc Biol 2001; 21: 1233-7.
Gillman MW, Cupples A, Gagnon D, Millen,
BE, Ellison RC,
Castelli WP. Margarine Intake and Subsequent Coronary Heart
Disease in Men. Epidemiology 1997; 8: 144-9.
Berghaus TM, Demmelmair H, Koletzko B.
Fatty acid composition
of lipid classes in maternal and cord plasma at birth. Eur J Pediatr
1998; 157: 763-8.
Elias SL, Innis SM. Infant plasma trans,
n-6, and n-3 fatty acids and
conjugated linoleic acids are related to maternal plasma fatty acids,
length of gestation, and birth weight and length. Am J Clin Nutr
2001; 73: 807-14.
Pax J, Douglass L, Sampugna J. Effects of
linolenic and trans-fattyadics
on neonatal survival of C57BL/6 Mice. J Nutr Biochem 1992;
3(7): 342-8.
Koletzko B. Trans fatty acids may impair
biosynthesis of long-chain
polyunsaturates and growth in man. Acta Paediatr 1992; 81: 302-6.
Decsi T, Tjoonk HM, Molnar SZ, Wildeman
JAL, Bakker RR,
Hadders-Algra M, Muskiet FAJ, Boersma ER. Trans fatty acids are
inversely related to arachidonic and docosahexaenoic acids and
positively related to mead acid in cord blood vessel lipids of term
infant. J Ped Gastroent Nutr 2001; 32: 395.
Olsen SF, Sřrensen JD, Secher NJ,
Hedegaard M, Henriksen TB,
Hansen HS, Grant A. Randomised controlled trial of effect of fish-oil
supplementation on pregnancy duration. Lancet 1992;339:1003-7.
Hornstra G. Essential fatty acids in
mothers and their neonates.
Am J Clin Nutr 2000; 71(5): 1262S-9S.
Craig-Schmidt MC. Isomeric fatty acids:
evaluating status and
implications for maternal and child health. Lipids 2001; 36:
997-1006.
Williams MA, King IB, Sorensen TK, Zingheim
RW, Troyer BL,
Zebelman AM, Luthy DA. Risk of Preeclampsia in Relation to
Elaidic Acid (Trans Fatty Acid) in Maternal Erythrocytes. Gynecol
Obstet Invest 1998; 46: 84-7.
Bakker N, vant Veer P, Zock PL, and
the Euramic Study Group.
Adipose Fatty Acids and Cancers of the Breast, Prostate and Colon:
An Ecological Study. Int J Cancer 1997; 72: 587-97.
Kohlmeier L, Simonsen N, van t Veer
P, Strain JJ, Martin-Moreno
JM, Margolin B, Huttunen JK, Fernández-Crehuet Navajas J,
Martin BC, Thamm M, Kardinaal AFM, and Kok FJ. Adipose Tissue
Trans Fatty Acids and Breast Cancer in the European Community
Multicenter Study on Antioxidants, Myocardial Infarction, and
Breast Cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 705-10.
Petrek JA, Hudgins LC, Ho M, Bajorumas DR,
and Hirsch J.
Fatty Acid Composition of Adipose Tissue, and Indication of Dietary
Fatty Acids, and Breast Cancer Prognosis. J Clin Oncol 1997;
15(49): 1377-84.
McKelvey W, Greenland S, Chen M-J,
Longnecker MP, Frankl HD,
Lee ER, and Haile RW. A Case-Control Study of Colorectal
Adenomatous Polyps and Consumption of Foods Containing
Partially Hydrogenated Oils. Cancer Epidemiol Biomarkers Prev
1999; 8: 519-24.
Slattery ML et al. Trans -fatty acids and
colon cancer. Nutr Cancer
2001; 39: 170-5.
Voorrips LE, Brants HAM, Kardinaal AFM,
Hiddink GJ, van den
Brandt PA, and Goldbohm RA. Intake of conjugated linoleic acid,
fat, and other fatty acids in relation to postmenopausal breast cancer:
the Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutr
2002; 76: 873-82.
von Mutius E, Weiland SK, Fritzsch C, Duhme
H, Keil U.
Increasing prevalence of hay fever and atopy among children in
Leipzig, East Germany. Lancet 1998; 351: 862.
Weiland SK, von Mutius E, Hüsing A, Asher
MI, on behalf of the
ISAAC Steering Committee. Intake of trans fatty acids and prevalence
of childhood asthma and allergies in Europe. Lancet 1999; 353:
2040-1.
The International Study of Asthma and
Allergies in Childhood
(ISAAC) Steering Committee. Worldwide variation in prevalence of
symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema:
ISAAC. Lancet 1998; 351: 1225-32.
Salmeron J, Hu FB, Manson JE, Stampfer MJ,
Colditz GA,
Rimm EB, Willett WC. Dietary fat intake and risk of type 2 diabetes
in women. Am J Clin Nutr 2001; 73: 1019-26.
Meyer KA, Kushi LH, Jacobs DR, Folsom AR.
Dietary Fat and
Incidens of Type 2 Diabetes in Older Iowa Women. Diabetes Care
2001; 24: 1528-35.
van Dam RM et al. Dietary fat and meat
intake in relation to risk of
type 2 diabetes in men. Diabetes Care 2001; 25: 417-24.
Bray GA, Lovejoy JC, Smith SR, DeLany JP,
Lefevre M, Hwang D,
Ryan DH, York DA. The Influence of Different Fats and Fatty Acids
on Obesity, Insulin Resistance and Inflammation. J Nutr 2002; 132:
2488-91.
Christiansen E, Schnider S, Palmvig B,
Tauber-Lassen E, Pedersen O.
Intake of a diet high in trans monounsaturated fatty acids or saturated
fatty acids. Effects on postprandial insulinemia and glycemia in obese
patients with NIDDM. Diabetes Care 1997; 20: 881-7
Alstrup KK, Gregersen S, Jensen HM, Thomsen
JL, Hermansen K.
Differential effects of cis and trans fatty acids on insulin release from
isolated mouse islets. Metabolism 1999; 48: 22-9.
Reitzenthaler KL et al. Estimation of
conjugated linoleic acid intake
by written dietary assessment methodologies underestimates actual
intake evaluated by food duplicate methodology. J Nutr 2001; 131:
1548-54.
Jiang J, Wolk A, Vessby B. Relation between
the intake of milk fat
and the occurrence of conjugated linoleic acid in human adipose
tissue. Am J Clin Nutr 1999; 70: 21-7.
Ricerus U, Arner P, Brismar K, Vessby B.
Treatment With Dietary
trans10cis12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin
Resistance in Obese Men With the Metabolic Syndrome. Diabetes
Care 2002; 25: 1516-21.
van Poppel G (on behalf of the TRANSFAIR
Study Group). Intake of
trans fatty acids in western Europe: the TRANSFAIR Study. Lancet
1998; 351: 1099.
Wolff RL, Precht D. A critique of 50-m
CP-Sil 88 Capillary collums
used alone to assess trans-unsaturated FA in foold: the case of the
TRANSFAIR study. Lipids 2002; 37: 627-9.
Hulshof KFAM, van Erp-Baart M-A,
Anttolainen M, Becker W,
Church SM, Couet C Hermann-Kunz E, Kesteloot H et al. Intake
of fatty acids in Western Europe with emphasis on trans fatty acids:
The TRANSFAIR study. Eur J Clin Nutr 1999; 53: 142-57.
Litin L, Sacks F. Trans-fatty-acid content
of common foods.
N Engl J Med 1993; 329: 1969-70.